NEW YORK (GenomeWeb News) — TriLink BioTechnologies will provide Osmetech Molecular Diagnostics with reagents for its new cystic fibrosis and warfarin sensitivity tests, TriLink said today.

TriLink said it will provide Osmetech with custom oligonucleotides required for its eSensor Cystic Fibrosis Carrier Detection System and its eSensor XT-8 System for warfarin sensitivity.

San Diego-based TriLink makes custom oligonucleotides, nucleoside triphosphates, and PCR products for the diagnostic and OEM markets.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Sponsored by

This webinar will address a range of methods for optimizing small RNA library preparation.

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.